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Background/aim: To investigate the relationship between imaging findings and peripheral blood cell counts of COVID-19 patients and
the degree of thymus fat involution of these patients.
Materials and methods: Computed tomography (CT) images of 87 patients with COVID-19 positive through RT-PCR testing
were evaluated retrospectively by two radiologists. Ground glass densities and other signs of viral pneumonia were recorded, lung
involvement was scored quantitatively. The patients thymus fat involution was graded on CT. Neutrophil-lymphocyte ratio (NLR),
platelet-lymphocyte ratios (PLR), lymphocyte and platelet counts were calculated. Imaging findings and degrees of thymus fat involution
were compared with laboratory data.
Results: Quantitative scoring of lung involvement was calculated at mean 6.63 ± 4.70 (1–23) for observer 1 and mean 6.55 ± 4.65
(1–23) for observer 2 (K = 0.824–1.000). Statistical significance was determined between the increase in age and the increase in scores
of lung findings (p = 0.003). Lymphocyte count (p = 0.0001) and PLR (p = 0.001) were significantly lower in patients with severe CT
involvement. A statistically significantcorrelation was found between increased thymus fat component and presence of COVID-19 lung
involvement in CT (r = 0.461).
Conclusion: The severity of imaging findings for COVID-19 patients significantly correlates with the degree of fat involution in patients’
thymus tissue.
Key words: COVID-19, pneumonia, chest, thymus, lymphocyte, platelet

1. Introduction
Having first appeared in Wuhan province of China in
December 2019, the outbreak of coronavirus disease
(COVID-19) has led to the deaths of hundreds of thousands
of people worldwide [1]. While the World Health
Organization (WHO) declared this situation as a pandemic
on 11 March 20201, the first COVID-19 cases in Turkey
were detected in March 20202. Coronaviruses found in the
etiology of the disease are positive-sensitive RNA viruses
within the Coronaviridae family. Two other important
diseases in the etiology of coronaviruses are severe acute
respiratory syndrome (SARS),which broke out in southern
China between 2002 and 2003, and the Middle East
respiratory syndrome (MERS), which continuedtill 2019
in Saudi Arabia [2]. The clinical findings of COVID-19 are

generally reported as high fever, weakness, muscle pain,
dry cough and shortness of breath. The reported labresults
are varied, and lymphopenia and thrombocytopenia are
observed in severe cases [3]. The definitive diagnosis of
2019-novel coronavirus is made by reverse-transcriptase
polymerase-chain reaction (RT-PCR) and computed
tomography (CT) is known to occupy a key role in the
diagnosis of COVID-19. The characteristics of imaging
findings and thoracic CT features during the onset and
progression of the disease have been defined [4–7] The
sensitivity and specificity of thorax CT in the diagnosis of
COVID-19 was reported as 97% and 57%, respectively [8].
Some recent research has revealed that neutrophillymphocyte (NLR) and platelet-lymphocyte ratio (PLR)
between severe and nonsevere cases in COVID-19 can
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1

2

Turkish Government, Ministery of Health (2020). Türkiye’deki Güncel Durum [online]. Website https://covid19.saglik.gov.tr/ [accessed 02 April 2020].

* Correspondence: vefacakm1408@gmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

991

ÇAKMAK et al. / Turk J Med Sci
prove effective in the prognosis of the disease [9–11].
Indeed, prognostic factors play a key role in this regard as
no effective treatment exists for COVID-19 thus far.
Thymus is the primary lymphoid organ supporting T
lymphocyte development, and normal thymus tissue as
well as fat infiltration is readily distinguishable in crosssectional imaging. As a result of irregularity in the cellmediated immune system and fatty involution of the
thymus, susceptibility to infections increases, and immunity
to vaccines decreases [12].
The major aim of the present study is to gain an insight
into the relationship between COVID-19 imaging findings
and NLR, PLR and peripheral blood cell numbers, in
addition to the link between laboraty and imaging findings
and thymus tissue of COVID-19 patients.
2. Materials and methods
2.1. Study group
Thoracic computed tomography (CT) images of the
patients presenting to the Emergency Department (ED) of
Pamukkale University Hospital with complaints, such as
fever, sore throat, dry cough, and shortness of breath were
assessed retrospectively. The diagnosis of COVID-19 was
confirmed as positive following the RT-PCR test of the nasal
and pharyngeal swab samples of these patients taken under
the guidelines of WHO. The medical history, examination
findings and labresults of our patients were obtained from
the hospital medical records. Of all these patients, those
with hematological or oncological disease, interstitial lung
disease, and diffuse respiratory motion artefacts in their
images were excluded from the study. CT images of 87
patients (53 males, 34 females, median age 45, mean 46.31
± 17.31 years) diagnosed with COVID-19 by RT-PCR test
were assessed by two radiologists with board certification.
2.2. Computed tomography
CT examinations were performed with a 16-slice helical
CT scanner (Brilliance; Philips Medical Systems, Cleveland,
OH, USA) and 2 slice helical CT scanners (GE Brivo,
Milwaukee, USA). These CT scanners were used only for
COVID-19 patients during the pandemic period by taking
the necessary disinfection and isolation precautions.
Planned on a scenogram image, CT examinations
wereperformedwhile the patients were in the supine
position and inspiration, with their arms next to their heads.
Besides, intravenous contrast media were not used. Thorax
CT imaging parameters in 2-slice helical CT scanner were
tube voltage 120 kV, tube current 100 mAs, collimation 2 ×
1.5 mm, and pitch 0.938, while those in 16-slice helical CT
scanner were tube voltage 120 kV, tube current 100 mAs,
collimation 16 × 0.75 mm, and pitch 1.063. The CT images
of all the patients were evaluated in mediastinum (WW:
350, WL: 50) and parenchyma (WW: –600, WL: 1600)
window on the workstation.
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2.3. Imaging analysis
The descriptive findings of viral pneumonia described
by the Fleischner Society were investigated in the CTs of
87 positive COVID-19 patients between March 15, 2020
and April 15, 2020 [13]. Accordingly, COVID-19 positive
patients were classified as with and without lung findings
during the admission to the ED. The presence of groundglass densities and the lobes where they are located were
evaluated and recorded for lung involvement. What
was probed, except for ground-glass densities, was the
presence of consolidation or nodule, crazy paving, halo
sign, enlarged vessel sign and air buble sign. Apart from all
these, the presence of pleural or pericardial effusion as well
as of lymphadenopathy (short axis size greater than 1 cm)
and their localizations were assessed in thorax CT images.
We quantitatively scored lung involvement of COVID-19
positive patients [14,15]. Accordingly, a total of 6 zones
(3 lobes in the right lung, 2 in the left, and lingula) were
scored between 0 and 4 points, based on the involvement
percentage. As shown in Figures 1a–1d, the scoring scale
for lung involvement was devised as such: 0 points = no
involvement, 1 point = involvement below 25%, 2 points =
26%–50% involvement, 3 points = 51%–75% involvement,
and 4 points = 76%–100% involvement. In the light of this
scoring, 8 or more points were considered as severe lung
involvement. Thymus was classified in accordance with
parenchyma attenuation in the thorax CT of all COVID-19
positive patients [12]. The grading system was formulated
as followsas shown in Figure 2a; grade 3 = complete fat
infiltration, Figure 2b; grade 2 = larger than 50% fat
infiltration of the thymus, Figure 2c; grade 1 = less than 50
% fat infiltration of thymus, half solid thymus tissue, and
Figure 2d; grade 0 = complete solid thymus tissue. Then,
the degree of attenuation of thymus tissue was compared
with our scores on CT for imaging findings of the disease.
Moreover, the ground glass placement in the group with
lung involvement was compared with lobar involvement,
consolidation, crazy paving findings and lymphocyte
values.
2.4. Laboratory data analysis
Before the onset of treatment administration in the ED for
the patients, peripheral blood sampling was performed
for complete blood count, c reactive protein, biochemical
and coagulation parameters. White blood cell count,
neutrophil, lymphocyte, monocyte and platelet count in
the complete blood count were recorded for the study.
Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte
ratio (PLR) and monocyte-lymphocyte ratio (MLO) were
calculated according to the routine peripheral blood
sample. These data obtained from peripheral blood sample
were compared with CT findings and scores in terms of the
presence and severity of lung involvement in COVID-19
positive patients.
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(a) 1 point (1-25% involvement) for the inferior lobe of the left lung.
Ground-glass opacities with reticular pattern with placement of the
superior segment of the inferior lobe of the right lung.

(c) 3 points for the superior lobe of the right lung
(50-75% involvement).

(b) 2 points for left lung superior lobe (25 - 50% involvement).

(d) 4 points for the superior lobe of the right lung
(75% or more involvement).

Figure 1a. Each lung lobe and lingula (six lung zones) were scored quantitatively (0–24 points). 1 point (1%–25% involvement) for the
inferior lobe of the left lung. Ground-glass opacities with reticular pattern with placement of the superior segment of the inferior lobe
of the right lung. b. Each lung lobe and lingula (six lung zones) were scored quantitatively (0–24 points). 2 points for left lung superior
lobe (25%–50% involvement). c. Each lung lobe and lingula (six lung zones) were scored quantitatively (0–24 points). 3 points forthe
superior lobe of the right lung (50%–75% involvement). d. Each lung lobe and lingula (six lung zones) were scored quantitatively (0–24
points). 4 points forthe superior lobe of the right lung (75% or more involvement).

2.5. Statistical analysis
Data analysis was performed using statistical software (SPSS
21 for Windows, Chicago, IL). The descriptive statistics
were expressed as mean ± standard deviation in continuous
variables and as % in categorical variables. Chi-square test
and Fisher’s exact test were run for categorical variables,
while the independent samples t-test was preferred to
compare the imaging findings and the degree of thymus fat
involution. The Mann–Whitney U test was used to compare
nonnormally distributed continious variables. Kolmogorov–
Smirnov tests were performed to check normal distribution
between the groups for continious variables. Univariate
logistic regression models were used to evaluate between

variables and lung involvement and adjusted odds ratio
(ORs) and 95% confidence intervals (CIs) were calculated.
Receiver operating characteristic (ROC) curve analysis was
performed to find an optimal cut-off value, sensitivity and
specificity of PLR. For all the abovementioned tests, p < 0.05
was considered as statistically significant. An interobserver
reliability analysis with the Cohen’s kappa statistic was
performed to identify the consistency among the raters.
3. Results
Eighty-seven patients diagnosed with COVID-19
(coronavirus disease 2019) through PCR were grouped by
age, comprising 32 patients between 20 and 40 years old,
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(a) Grade 3. Complete fatty degeneration of the thymus.

(b) Grade 2. Thymus gland is mostly fatty and reticulonodular
densities are observed.

(c) Grade 1. The thymus is triangular in shape and consists
of half solid and half fatty tissue.

(d) Grade 0. Solid thymus tissue consisting of the majority soft tissue.

Figure 2a. Axial thorax CT images in which the degree of thymus atenuation is assessed. Grade 3. Complete fatty degeneration of the
thymus. b. Axial thorax CT images in which the degree of thymus atenuation is assessed. Grade 2. Thymus gland is mostly fatty and
reticulonodular densities are observed. c. Axial thorax CT images in which the degree of thymus atenuation is assessed. Grade 1. The
thymus is triangular in shape and consists of half solid and half fatty tissue. d. Axial thorax CT images in which the degree of thymus
atenuation is assessed. Grade 0. Solid thymus tissue consisting of the majority soft tissue.

32 patients between 41 and 60 years old, and 23 patients
over 61 years old. CT findings were detected in 56 patients
with COVID-19 (64.4%) at the time of their admission, yet
no evidence of COVID-19 involvement in thorax CTs was
found for the remaining 31 patients (35.6%).
3.1. Distribution of lung findings and quantitative
scoring
Multilobar involvement was observed in 45 of 56 (80.35%)
patients with lung involvement in their CTs. The groundglass densities detected in the CTs of 56 patients were
characterized by a peripheral location only for 43 patients
(76.78%) while 13 patients (23.12%) showed both central
and peripheral locations. Crazy paving findings were
identified for 15 patients (26.78%), consolidation for 11
patients (19.64%), halo findings for four patients (7.14%),
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and air bubble findings for one patient. Four patients
(7.14%) had pleural effusion while 10 patients (17.85%)
had septal thickening or pleural shrinkage at the lowerlobes lesion level. For eight patients (14.28%), a lymph
node with a short axis size of over 1 cm was detected in
the mediastinum.
COVID-19-positive patients’ lung involvement was
scored for each lobe and lingula. Accordingly, the mean
lung score was calculated as 6.63 ± 4.70 (1–23) by observer
1 and 6.55 ± 4.65 (1–23) by observer 2 (K = 0.824–1.000).
The interobserver reliability for lung parenchymal
involvement was quite high. The mean score of the
patients between 20 and 40 years old (n = 32) was 1.97 ±
3.93, whereas the mean score of the patients between 41
and 60 years old (n = 32) was 5.41 ± 5.85, and the mean
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score of patients over 61 years old (n = 23) was 5.87 ± 4.26.
A statistical significance was found between increases in
age and increases in scores for the lung findings among
COVID-19 patients (p = 0.003). Ground-glass densities
and other findings indicating lung involvement were
located more commonly in both the lower lobes (78.6%)
and located less in the middle lobe (64.29%) and the
lingula (51.78%) (Table 1).
3.2. CT findings and lab analysis
For patients with COVID-19 imaging findings in thorax
CTs, a significant decrease was observed in white blood
cell (WBCs), neutrophil, lymphocyte, and monocyte
counts compared to patients without lung involvement
(Table 2). To achieve homogenous distribution, the
scoring of lung involvement was divided into two groups
as 0–8 points (disease with mild involvement) and 9–24
points (disease with severe involvement). Within this
framework, lymphocyte counts for patients with severe
involvement were significantly lower than for patients with
mild involvement (p = 0.0001), just as PLR was found to
be significantly lower for patients with severe involvement
than patients with mild involvement (p = 0.001). Further,
a significant decrease was observed in lymphocyte counts

(p = 0.005) and platelet count (p = 0.0001) for patients with
crazy paving CT findings.
3.3. Relationship between thymus and COVID-19
findings
Of 87 COVID-19-positive patients, 6 had thymus
attenuation at grade 0, 18 at grade 1, 29 at grade 2, and 34
at grade 3.The interobserver reliability of grading thymus
fat infiltration seemed remarkably high (K: 0.991). As
summarized in Table 3, a significant relationship was
identified between the increased thymus fat component and
the presence of COVID-19 lung involvement via CT (p =
0.029). Another significant relationship was found between
a decrease in the thymus attenuation degree and multilobar
involvement (p = 0.001). A moderate positive correlation
was found between the degree of thymus fat infiltration
and the presence of pulmonary findings (r = 0.461), and
a high positive correlation was found between the degree
of thymus fat infiltration and age (r = 0.603) (p < 0.0001).
A moderate negative correlation was found between the
degree of thymus fat infiltration and the lymphocyte counts
(r = –0.461, p = 0.001), and a moderate positive correlation
was found between the degree of thymus fat infiltration
and NLR (r = 0.489, p < 0.0001) (Table 4).

Table 1. Quantitative scoring in COVID-19 pneumonia.
Right

Superior lobe

Middle lobe

Inferior lobe

Left
O1

O2

No signs of
pneumonia

17

17

0%–25%

22

21

26%–50%

11

12

51%–75%

5

76%–100%

Kappa

O1

O2

No signs of
pneumonia

22

22

0%–25%

24

23

26%–50%

6

7

5

51%–75%

3

3

1

1

76%–100%

1

1

No signs of
pneumonia

20

24

No signs of
pneumonia

27

27

0%–25%

29

25

0%–25%

22

22

26%–50%

5

5

26%–50%

6

6

51%–75%

1

1

51%–75%

0

0

76%–100%

1

1

76%–100%

1

1

No signs of
pneumonia

12

12

No signs of
pneumonia

12

12

0%–25%

11

12

0%–25%

16

17

26%–50%

20

20

26%–50%

17

18

51%–75%

12

11

51%–75%

11

9

76%–100%

1

1

76%–100%

0

0

0.824

0.882

0.952

Superior lobe

Lingula

Inferior lobe

Kappa

0.945

1.000

0.952

O1= Observer 1, O2= Observer 2.
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3.51±3.04

167.85±78.65 140.84±90.23 0.006

0.34±0.22

NLR

PLR

MLR

0.178

0.873

0.37±0.19

1.25±0.47
0.051

2.24±4.06

2.71±3.47

0.027

–1.347 0.21±0.21

0.25±0.21

0.122

–2.747 122.80±71.30 181.23±96.45 0.001

–0.16

Positive
(n=15)
Mean±SD

–1.182 3.49±1.93

–2.597 5.15±2.08

z

0.46±0.20

1.84±0.99

4.39±2.89

7.45±3.15

Negative
(n=41)
Mean±SD

0.016

0.005

0.042

0.002

p

Positive
(n=11)
Mean±SD

–2.406 0.49±0.23

–2.837 1.24±0.54

–2.034 3.65±1.75

–3.096 5.26±2.09

z

Consolidation

0.44±0.20

1.76±0.99

4.35±2.90

7.22±3.19

Negative
(n=45)
Mean±SD

z

0.687 –0.402

0.088 –1.705

0.237 –1.181

0.066 –1.839

p

2.36±4.15

0.286

–1.548 0.24±0.18

0.22±0.21

0.633

–3.267 129.54±81.24 131.02±84.37 0.406

–2.213 2.62±2.42

2.45±4.11

0.474 –0.715

–0.478 0.25±0.18

0.22±0.21

0.697 –0.390

–0.832 146.40±56.36 130.21±86.92 0.235 –1.188

–1.067 2.69±1.89

–1.948 163.00±45.18 236.00±65.23 0.0001 –3.826 189.00±92.09 227.00±62.79 0.115 –1.577

–1.948 0.35±0.18

0.0001 –3.709 1.22±0.44

0.237

0.009

p

–2.172 223.00±54.60 207.00±93.26 0.158

–1.769 0.47±0.20

3.86±2.51

5.53±2.63

9–23
(n=24)
Mean±SD

Crazy paving

10

11

3

0.029

Grade 2

Grade 1

Grade 0

p

3

7

19

27

0.050

3

6

12

11

N= Number of patients, CT = Computed tomography

7

1–8
(n=32)

Negative
(n=31)

Positive
(n=56)

Scoring

CT findings

Grade 3

The degree
of thymus fat
involution

0

1

7

16

9–23
(n=24)

0.768

3

5

14

21

Peripheral
(n=43)

0

2

5

6

Peripheral +
central (n=13)

Ground glass densities

Table 3. Comparison of the degree of thymus fat involution with CT findings.

0.001

3

2

5

1

Negative
(n=11)

0

5

14

26

Positive
(n=45)

0.084

3

7

15

16

Negative
(n=41)

0

0

4

11

Positive
(n=15)

Multilobar involvement Crazy paving

0.453

2

7

14

22

Negative
(n=45)

1

0

5

5

Positive
(n=11)

Consolidation

N= Number of patients, WBC= White blood cell, NLR= Neutrophil-lymphocyte ratio, PLR= Platelet- lymphocyte ratio, MLR= Monocyte- lymphocyte ratio, CT = Computed
tomography, COVID-19= Coronavirus disease, SD= Standart deviation.

0.30±0.21

4.37±5.13

225.75±74.65 248.29±48.10 0.03

Platelet(K/uL)

0.77

0.54±0.22

4.37±2.88

7.46±3.16

0.0001 –3.492 1.97±1.01

2.24±1.02

0.45±0.19

Monocyte(K/uL)

0.0001 –4.09

0.0001 –4.68

Lymphocyte(K/uL) 1.59±0.85

6.50±2.91

4.31±2.43

Neutrophil(K/uL)

9.46±2.86

6.45±2.75

WBC(K/uL)

z

1–8
(n=32)
Mean±SD

p

Positive
(n=56)
Mean±SD

Negative
(n=31)
Mean±SD

Scoring

CT findings

Table 2. Comparison of COVID-19 CT findings with hemogram data.
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3.4. The univariate logistic regresion models and ROC
curve analysis
Univariate analysis indicated that neutrophil (OR = 0.740,
95% CI, 0.616–0.890, p < 0.0001), lymphocyte (OR = 0.466,
95% CI, 0.271–0.802, p = 0.006), WBC (OR = 0.702, 95%
CI, 0.587–0.840, p = < 0.0001), and thymus fat involution
(OR = 0.511, 95% CI, 0.310–0.841, p = 0.008) values
positively correlated with lung involvement (Table 5). The
area under ROC curve (AUC) was 0.679 (95% confidence
interval, CI: 0.552–0.805) for PLR. Figure 3 shows that the
cut-off PLR value for lung involvement was 103.88 while
sensitivity was 84% and specificity was 55% (p = 0.006).
4. Discussion
Our study indicates that CT findings and quantitative
CT scores tend to increase in parallel with increasing fat
attenuation in the thymus. We also noted a significant
relationship between increased fat attenuation in the
thymus and decreased lymphocyte counts in the patients
of our study group. The most important cause of fat
infiltration in the thymus is age, and COVID-19 shows
higher lung involvement for patients of older ages. In
our study, we found a statistically significant positive
correlation between age and thymus fat infiltration. In
addition, our study found a moderate positive correlation

between the degree of thymus fat infiltration and the
presence of pulmonary findings. In this study, in 23 patients
over the age of 40 years with mild lung involvement,
thymus tissue attenuation was observed as grades 0 and
1. For three patients over the age of 40 years, their thymus
tissue was almost completely solid, and lung involvement
was not observed. We can, thus, conclude that thymus
size and amounts of fat involution also play a key role in
coronavirus disease 2019, in addition to amounts of T
lymphocytes.
Neutrophil increases and decreases in lymphocyte
counts, as well as multilobar involvement, were
documented as more pronounced among elderly patients
than young patients. Changes in the respiratory system’s
anatomical and physiological functions, in addition to a
weakened defense barrier, were claimed to be potentially
responsible for the higher severity of COVID-19 among
elderly patients [16,17]. Likewise, lung involvement scores
were ultimately found to be higher among the elderly
group in our study. Amounts of thymus fat involution were
also higher among the elderly group compared to their
younger counterparts, and decreased lymphocyte counts
were more evident.
A higher amount of proinflammatory cytokines (TNFalpha, IL-1, IL-6) and chemokines were noted in patients

Table 4. Correlation of blood cell count with the degree of attenuation of thymus tissue.

The degree of
attenuation of thymus
tissue

WBC

Neutrophil

Lymphocyte

Monocyte

Platelet

NLR

PLR

r

–0.064

–0.176

–0.425

0.181

–0.304

0.489

0.314

p

0.642

0.195

0.001

0.181

0.023

0.000

0.018

WBC= White blood cell, NLR= Neutrophil-lymphocyte ratio, PLR= Platelet-lymphocyte ratio.
Table 5. Results of univariatelogistic regression for lung involvement.
β

p value

Odds ratio

Confidence interval

WBC

–0.354

0.0001

0.702

0.587

0.840

Neutrophil

–0.301

0.001

0.740

0.616

0.890

Lymphocyte

–0.763

0.006

0.466

0.271

0.802

Platelet

–0.005

0.140

0.995

0.988

1.002

Monocyte

–2.175

0.052

0.114

0.013

1.022

NLR

–0.054

0.336

0.947

0.848

1.058

PLR

0.004

0.155

1.004

0.998

1.011

MLR

0.982

0.383

2.670

0.294

24.284

WBC= White blood cell, NLR= Neutrophil-lymphocyte ratio, PLR= Platelet-lymphocyte ratio,
MLR= Monocyte-lymphocyte ratio.
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Figure 3. ROC curve for platelet to lymphocyte ratio.

with severe COVID-19 findings compared to patients
with mild symptoms [18]. In COVID-19 pathogenesis,
lung findings have been reported to depend on a rise
in serum cytokine and chemokine levels. In addition,
a decreasing lymphocyte count and an increasing
neutrophil-lymphocyte ratio were observed for patients
with severe symptoms [19]. Some studies also established
NLR as an independent risk factor for mortality and
prognosis, notably in men [10]. No significant change
occurred in lymphopenia B cells and CD8 + Tlenfocyte
counts for severe COVID-19 patients, while a decrease
in CD4 + T lymphocyte counts was noted [20]. Some
research predicted that lymphopenia could be caused by
direct virus attacks, attacks by inflammatory mediators, or
lymphocytes’ passage from peripheral blood to the lungs
[21,22]. In our study, we established a significant decrease
in lymphocyte counts for patients with COVID-19 whose
imaging findings were positive, whose CT findings’ severity
increased, and whose crazy paving findings were detected
in CTs. On the other hand, we did not find any significant
NLR rate differences in CT findings and quantitative
scoring. We suggest that the thymus plays a critical role in
this disease in light of the data, such as lymphopenia and
NLR, utilized for COVID-19 patients’ prognoses. Qin et al.
documented that CD4 + T cells tend to decrease without
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any significant changes in B lymphocyte and CD8 + T
lymphocyte counts [19].
The platelet-lymphocyte ratio (PLR) is one marker of
systemic inflammation. Qu et al. suggested that the length
of a patient’s hospital stay positively correlated with their
age and platelet levels, though negatively correlating with
lymphocyte levels. In their study, which calculated a PLR
cut-off value at PLR > 126.7, COVID-19 patients’ high PLR
was reported to extend the length of their hospital stays,
and PLR was associated with disease prognosis [11]. In
our study, meanwhile, we found 84% sensitivity and 55%
specificity, while our PLR cut-off value was 103.88 for lung
involvement (p = 0.006). PLR proved to be significantly
higher for patients with severe disease involvement
than patients with mild disease involvement. Given the
increased CT findings, we linked these patients’ PLR
increases to lymphopenia, and we observed a significant
decrease in platelet counts for patients with crazy paving
findings via CT.
In our study, we quantitatively scored COVID-19
thorax CT findings by calculating each lung lobe’s
proportion of involvement. As a result, we found mean
scores for involvement of 6.63 ± 4.70 by observer 1 and
of 6.55 ± 4.65 (1–23) by observer 2. Within the context
of our study group, a significant increase was observed
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in lung findings scores, with increases according to age.
Previous research that had based quantitative evaluation
on a scoring system ultimately revealed the prognosis of
patients with high scores to be poor [6,14,23].
This study was planned using an interobserver design
in which CT images of COVID-19 patients were assessed
by two radiologists. Excellent agreement was achieved
between the two interobservers for quantitative scoring
of the CT findings, patients’ thymus imaging features, and
the CT findings themselves.
Our study involved some limitations. The first limitation
concerned the study’s retrospective characteristic, whereas
the second limitation was our inability to follow up on our
COVID-19 patients’ CT findings. CT examinations were
not repeated-not only because these patients’ follow-up
imaging findings abound in the literature in detail but
also to prevent patients’ re-exposure to the radiation of
a CT scan. Third, these patients’ follow-up lab data were
not evaluated; instead, patients’ CTs at the time of their
admission to the emergency department were compared
with their first lab data. Moreover, patients’ thymic volumes
could not be measured. While our COVID-19 patients’
general symptoms were characterized by shortness of
breath and coughing, an optimal quantitative evaluation
could not be performed due to breathing-related artifacts
during CT scans. Another limitation was that patients in

the study group were not grouped according to their age
and correlations in each age group were not calculated
separately. A separate correlation calculations for each
age could be helpful in demonstrating the relationship
between COVID-19 and thymus fat involution, regardless
of age. Finally, the type and duration of treatment for these
patients, as well as the data’s effect on the duration of their
hospitalization upon their admission to the emergency
department, were not evaluated.
In conclusion, our study shows that imaging findings’
severity correlates significantly with COVID-19 patients’
platelet-lymphocyte ratios and that decreased platelet
and lymphocyte counts lead to observable increases in
imaging findings. The severity of imaging findings for
COVID-19 patients significantly correlates with the level
of fat involution in patients’ thymus tissue. Future studies
conducted on the thymus would contribute substantially
to coronavirus disease 2019 treatment and prognosis.
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